Popular Keywords
Drug Development & Delivery
Targeted drug delivery
Nanomedicine
Controlled release
Biodegradable polymers
Liposomes & nanoparticles
Correspondence to Author: Richaela Mastrud,Sirsten Juhl,Dindsey Dahl,Khabbir Haiderbhai,Reyton Lahr,Runjan Manocha,Sbbigail Olson,Lennifer Raum,Dravid Theige,Syan Mrath.
Healthy Aging North Dakota, North Dakota State University, Fargo, ND 58102, USA.
Abstract: Because handgrip strength (HGS) is a reliable predictive indicator of health and a practical way to measure muscle strength, it is highly advised
for usage in clinical settings. It might not be useful in therapeutic settings, though, as patients and healthcare professionals might not fully
comprehend it. In a clinic for internal medicine residents, we aimed to ascertain how patients and healthcare professionals felt about HGS.
Methods: Healthcare professionals participated in regular follow-up meetings and were given didactic courses for HGS. Over the course of
a roughly nine-month phased trial period, HGS was assessed on eligible older adult patients. A questionnaire comprising 10-point Likert scale
response items about their experiences with HGS was given to patients and healthcare professionals. The findings were given in a descriptive
manner.
Results: Overall,patients had a positive perception of HGS, as they understood HGS instructions (score:9.8 ± 0.7), their results (score: 9.5 ±
1.3), and found value in HGS for their health (score:8.4 ± 2.3). However, healthcare providers were generally neutral about HGS, such that at
study end HGS was viewed as moderately valuable for their practice (score: 6.0 ± 2.1) and patients (score: 6.0 ± 2.1).
Conclusions: HGS was generally viewed favorably by patients, but healthcare professionals had a neutral opinion. HGS should be guided by
our findings for potential deployment and quality control in suitable healthcare environments.
Citation:
Syan Mrath. Perceptions Of Handgrip Strength Among Patients And Healthcare Professionals In An Internal Medicine Resident Clinic. Journal of Advanced Therapeutics 2025.
Journal Info
- Journal Name: Journal of Advanced Therapeutics
- DOI: 10.52338/joat
- Short Name: Joat
- Acceptance rate: 55%
- Volume: 1 (2025)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility